It is indicated for the: 1.Treatment and prevention of postmenopausal osteoporosis in women. 2.Treatment and prevention of osteoporosis in men.
One tablet of Ibandronic Acid 150 mg once monthly of the same date of each month is recommended. To maximize clinical benefit of Ibandronic acid, two tablets of Calcium Orotate 400 mg per day are usually recommended in divided dosage.
Ibandronic Acid: Products containing calcium and other multivalent cautions (such as aluminium, magnesium, iron) are likely to interfere with absorption of Ibandronic Acid. Ibandronic Acid should be taken at least 60 minutes before any oral medications. Aspirin, NSAIDs, and bisphosphonates are all associated with gasrointestinal irritation, caution should be exercised in the concomitant use of aspirin of NSNADs with Ibandronic Acid.
Calcium Orotate: Calcium can decrease the absorption of the other drugs such as bisphosphonates (e.g., alendronate/risedronate), quinolone antibiotics (e.g., ciprofloxacin, levofloxacin), and tetracycline antibiotic (e.g., doxycycline, levofloxacin).
Take special care if you have-Low blood circular level (hypocalcaemia); Cannot sit or stand up for 60 minutes; Have an allergy to Ibandronate Sodium; Are pregnant or may become pregnant; Are breast feeding or plan to breast feed; Adequate intake of Calcium and Vitamin D is important in all patients; Patients should follow the dosing instructions to minimize the risk of gastrointestinal side effects
Ibandronic Acid Common side effects include Hypertension, Dyspepsia, Nausea, Diarrhea, Abdominal Pain, Arthralgia, Back Pain, Localized Osteoarthritis, Myalgia, Muscle Cramp, Influenza, Nasopharyngitis, Bronchitis, Urinary Tract Infection, Upper Respiratory Tract Infection, Headache, Dizziness, Skin Rash, Insomnia etc. Calcium Orotate Bloating and swelling in the abdomen are common side effects of Calcium Orotate. Loss of appetite, upset stomach, constipation, nausea, vomiting, unusual weight loss, mood changes, bone/muscle pain, headache, increased thirst/urination, weakness, unusual tiredness, formation of kidney stones may occur infrequently.
There are no adequate and well controlled studies in pregnant women for it. It should be used during pregnancy only if the potential benefit justifies the potential risk to the mother and fetus.
Store in a cool & dry place, protected from light. Keep all medicines out of reach of children.
.png&w=384&q=75)